Related Experiment Videos
Management of malignant pleural effusions
1Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, Charleston, South Carolina, USA. sahnsa@musc.edu
Summary
Malignant pleural effusions, common in lung and breast cancer, cause dyspnea. Effective palliation involves assessing the patient and choosing the least invasive treatment, like chemical pleurodesis with talc slurry, for optimal quality of life.
Area of Science:
- Pulmonology
- Oncology
- Palliative Care
Background:
- Malignant pleural effusions (MPEs) are common in advanced lung and breast cancer.
- MPEs significantly impact patient quality of life, primarily through dyspnea.
Purpose of the Study:
- To review current palliative treatment options for malignant pleural effusions.
- To emphasize patient assessment for selecting the most effective and least invasive therapy.
Main Methods:
- Review of therapeutic modalities for MPE palliation.
- Discussion of chemical pleurodesis, indwelling catheters, and surgical options.
- Analysis of factors influencing treatment selection, including patient status and response to initial procedures.
Main Results:
- Chemical pleurodesis, particularly talc slurry, is highly effective for MPE palliation.
- Chronic indwelling catheters offer an alternative, and pleuroperitoneal shunting benefits specific cases.
- Parietal pleurectomy is reserved for refractory cases or trapped lungs.
Conclusions:
- Optimal palliation of MPEs requires comprehensive patient assessment and selection of the least invasive, morbid, and costly therapy.
- Successful initial treatment is crucial to minimize patient burden and healthcare costs.